Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Tuesday, August 5, 2025
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Hims & Hers (HIMS) Q2 earnings 2025

August 5, 2025
in News
Reading Time: 3 mins read
A A
Hims & Hers (HIMS) Q2 earnings 2025
0
SHARES
ShareShareShareShareShare

READ ALSO

India calls out EU and U.S.’ trade with Russia after Trump threatens steeper tariffs

Palantir PLTR Q2 earnings 2025

The Hers app arranged on a smartphone in New York on Feb. 12, 2025.

Gabby Jones | Bloomberg | Getty Images

Shares of Hims & Hers Health fell 9% in extended trading on Monday after the telehealth company reported second-quarter results that missed Wall Street’s expectations for revenue.

Here’s how the company did based on average analysts’ estimates compiled by LSEG:

  • Earnings per share: 17 cents adjusted vs. 15 cents expected
  • Revenue: $544.8 million vs. $552 million expected

Revenue at Hims & Hers increased 73% in the second quarter from $315.6 million during the same period last year, according to a release. Hims & Hers reported a net income of $42.5 million, or 17 cents per share, compared to $13.3 million, or 6 cents per share, during the same period a year earlier.

For its third quarter, Hims & Hers said it expected to report revenue between $570 million and $590 million, while analysts were expecting $583 million. The company said its adjusted earnings before interest, taxes, depreciation and amortization, or EBITDA, for the quarter will be between the range of $60 million and $70 million. Analysts polled by StreetAccount were expecting $77.1 million.

Hims & Hers has faced controversy in recent months over its continued sale of compounded GLP-1s, which are cheaper, unapproved versions of the blockbuster diabetes and weight loss drugs. Compounded drugs can be mass-produced when brand-name treatments are in shortage, but the U.S. Food and Drug Administration announced in February that ongoing supply issues had been resolved.

Some telehealth companies, including Hims & Hers, have continued to offer the compounded medications. It’s legal for patients to access personalized doses of the knockoffs in unique cases, such as if they are allergic to an ingredient in a branded product, for instance. Hims & Hers has said consumers may still be able to access personalized doses through its site if clinically applicable. 

In June, Hims & Hers shares tumbled more than 30% after a short-lived collaboration with Novo Nordisk fell apart. The drugmaker said Hims & Hers “failed to adhere to the law which prohibits mass sales of compounded drugs” under the “false guise” of personalization.

Hims & Hers reported adjusted EBITDA of $82 million for its second quarter, up from $39.3 million last year and above the $73 million expected by StreetAccount.

Hims & Hers will host its quarterly call with investors at 5 p.m. ET.

Don’t miss these insights from CNBC PRO

Stock Chart IconStock chart icon

Hims & Hers (HIMS) Q2 earnings 2025

YTD chart of Hims & Hers Health.

— CNBC’s Annika Kim Constantino contributed to this report.

Credit: Source link

ShareTweetSendSharePin
Previous Post

Dan Patrick calls out Bronny James for missing Luka Doncic press conference

Next Post

After Figma’s red hot IPO, investors say these companies may be next to IPO

Related Posts

India calls out EU and U.S.’ trade with Russia after Trump threatens steeper tariffs
News

India calls out EU and U.S.’ trade with Russia after Trump threatens steeper tariffs

August 5, 2025
Palantir PLTR Q2 earnings 2025
News

Palantir PLTR Q2 earnings 2025

August 5, 2025
Tesla awards Musk  billion in shares with 2018 pay package in limbo
News

Tesla awards Musk $29 billion in shares with 2018 pay package in limbo

August 4, 2025
Nvidia might not recover its market share in China
News

Nvidia might not recover its market share in China

August 4, 2025
Swiss tensions run high as clock ticks on U.S. tariff deadline
News

Swiss tensions run high as clock ticks on U.S. tariff deadline

August 4, 2025
Parents who are good at handling tantrums use 7 phrases with their kids
News

Parents who are good at handling tantrums use 7 phrases with their kids

August 3, 2025
Next Post
After Figma’s red hot IPO, investors say these companies may be next to IPO

After Figma’s red hot IPO, investors say these companies may be next to IPO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

Volvo Cars switches gears in the U.S. as Trump’s tariffs bite

Volvo Cars switches gears in the U.S. as Trump’s tariffs bite

July 17, 2025
Sports and entertainment mogul accused of making secret backroom deal in 8 million arena project

Sports and entertainment mogul accused of making secret backroom deal in $338 million arena project

July 10, 2025
Ex-pro wrestling star Buff Bagwell gets right leg amputated: ‘This is hard’

Ex-pro wrestling star Buff Bagwell gets right leg amputated: ‘This is hard’

July 20, 2025
[Webinar] Food Traceability in Focus: What Your FSMA 204 Game Plan Might Be Missing

[Webinar] Food Traceability in Focus: What Your FSMA 204 Game Plan Might Be Missing

July 16, 2025
The new 8BitDo Pro 3 gamepad is open for pre-order now

The new 8BitDo Pro 3 gamepad is open for pre-order now

July 15, 2025
Save on MacBooks, Windows 11 machines, Chromebooks and others before the sale ends

Save on MacBooks, Windows 11 machines, Chromebooks and others before the sale ends

July 11, 2025
From Irish whiskey to Italian cheese, U.S. tariffs rattle EU exporters

From Irish whiskey to Italian cheese, U.S. tariffs rattle EU exporters

July 19, 2025

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • India calls out EU and U.S.’ trade with Russia after Trump threatens steeper tariffs
  • Napheesa Collier out at least two weeks in Lynx injury blow
  • After Figma’s red hot IPO, investors say these companies may be next to IPO
  • Hims & Hers (HIMS) Q2 earnings 2025

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In